EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Disease and Condition

Humate-P Approved To Prevent Excessive Bleeding In Patients With Von Willebrand Disease Undergoing Surgery

Humate-P, CSL Behring's factor replacement therapy for the treatment of hemophilia A and von Willebrand disease, has been approved by FDA to prevent excessive bleeding during and after surgery, in patients with severe VWD and mild to moderate VWD.

Pages